HNF1A and bone benign neoplasm: Our results indicated that the expression levels of HNF1A‐AS1 were significantly decreased in patients with post‐operative chemotherapy (19.14 ± 2.21) to a level that was similar to that of healthy donors and patients with benign bone tumour (23.63 ± 2.27).